132 related articles for article (PubMed ID: 37883921)
21. Are hypertension and diabetes mellitus risk factors for pelvic organ prolapse?
Isık H; Aynıoglu O; Sahbaz A; Selimoglu R; Timur H; Harma M
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():59-62. PubMed ID: 26706923
[TBL] [Abstract][Full Text] [Related]
22. Traction on the cervix in theatre before anterior repair: Does it tell us when to perform a concomitant hysterectomy?
Foon R; Agur W; Kingsly A; White P; Smith P
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):205-9. PubMed ID: 22129812
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of histological abnormalities in hysterectomy specimens performed for prolapse. A systematic review and meta-analysis.
Nicholson RC; Khunda A; Ballard P; Rees J; McCormick C
Int Urogynecol J; 2021 Dec; 32(12):3131-3141. PubMed ID: 34115164
[TBL] [Abstract][Full Text] [Related]
24. Pelvic organ prolapse surgery following hysterectomy with benign indication: a national cohort study in Taiwan.
Huang HK; Ding DC
Int Urogynecol J; 2018 Nov; 29(11):1669-1674. PubMed ID: 29923012
[TBL] [Abstract][Full Text] [Related]
25. Unexpected premalignant gynecological lesions in women undergoing vaginal hysterectomy for utero-vaginal prolapse.
Elbiaa AA; Abdelazim IA; Farghali MM; Hussain M; Omu AE
Prz Menopauzalny; 2015 Sep; 14(3):188-91. PubMed ID: 26528108
[TBL] [Abstract][Full Text] [Related]
26. Preliminary study of confocal laser endomicroscopy for in vitro specimens of the endometrium.
Wen J; Yang X; Ye G; Chen R; Feng Y; Liao Q
BMC Cancer; 2022 Oct; 22(1):1094. PubMed ID: 36284282
[TBL] [Abstract][Full Text] [Related]
27. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
28. Risk factors for vaginal prolapse after hysterectomy.
Lukanovic A; Drazic K
Int J Gynaecol Obstet; 2010 Jul; 110(1):27-30. PubMed ID: 20362288
[TBL] [Abstract][Full Text] [Related]
29. Hysterectomy on benign indication and risk of pelvic organ prolapse surgery: A national matched cohort study.
Aagesen AH; Klarskov N; Gradel KO; Husby KR
Acta Obstet Gynecol Scand; 2023 Jun; 102(6):774-781. PubMed ID: 37013371
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of Oophorectomy at the Time of Vaginal Hysterectomy in Patients with Pelvic Organ Prolapse.
Lua LL; Kosiorek HE; Wasson MN
J Minim Invasive Gynecol; 2019; 26(6):1063-1069. PubMed ID: 30343033
[TBL] [Abstract][Full Text] [Related]
31. Statewide geographic variation in hysterectomy approach for pelvic organ prolapse: a county-level analysis.
Latack KR; Moniz M; Hong CX; Schmidt P; Malone A; Kamdar N; Madden B; Pizzo CA; Thompson MP; Morgan DM
Am J Obstet Gynecol; 2023 Sep; 229(3):320.e1-320.e7. PubMed ID: 37244455
[TBL] [Abstract][Full Text] [Related]
32. Abnormal Pathology Following Vaginal Hysterectomy for Pelvic Organ Prolapse Repair.
Geron Y; From A; Peled Y; Zeevi G; Matot R; Nachshon S; Krissi H
J Womens Health (Larchmt); 2024 May; ():. PubMed ID: 38700374
[No Abstract] [Full Text] [Related]
33. Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer.
He SM; Xing F; Sui H; Wu Y; Wang Y; Wang D; Chen G; Kong Z; Zhou SF
Med Sci Monit; 2011 Nov; 17(11):CR618-625. PubMed ID: 22037740
[TBL] [Abstract][Full Text] [Related]
34. Pelvic organ prolapse after laparoscopic hysterectomy compared with vaginal hysterectomy: the POP-UP study.
Vermeulen CKM; Veen J; Adang C; van Leijsen SAL; Coolen AWM; Bongers MY
Int Urogynecol J; 2021 Apr; 32(4):841-850. PubMed ID: 33170314
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of endometrial evaluation prior to morcellation in surgical procedures for prolapse.
McPencow AM; Erekson EA; Guess MK; Martin DK; Patel DA; Xu X
Am J Obstet Gynecol; 2013 Jul; 209(1):22.e1-9. PubMed ID: 23545164
[TBL] [Abstract][Full Text] [Related]
36. [Surgical treatment of precancer and cancer of endometrium].
Ivanov S; Khadzhiolov N; Batashki I
Akush Ginekol (Sofiia); 2007; 46(6):12-4. PubMed ID: 17974165
[TBL] [Abstract][Full Text] [Related]
37. Uterine preservation vs hysterectomy in pelvic organ prolapse surgery: a systematic review with meta-analysis and clinical practice guidelines.
Meriwether KV; Antosh DD; Olivera CK; Kim-Fine S; Balk EM; Murphy M; Grimes CL; Sleemi A; Singh R; Dieter AA; Crisp CC; Rahn DD
Am J Obstet Gynecol; 2018 Aug; 219(2):129-146.e2. PubMed ID: 29353031
[TBL] [Abstract][Full Text] [Related]
38. The Incidence and Clinical Significance of Atypical Glandular Cells of Undetermined Significance on Cervical Pap Smears.
Al-Rayyan E; Rashed M; Maaita M; Qudah S; Taso O; Haddadin W
Gulf J Oncolog; 2019 May; 1(30):52-56. PubMed ID: 31242982
[TBL] [Abstract][Full Text] [Related]
39. Quality of life following vaginal reconstructive versus obliterative surgery for treating advanced pelvic organ prolapse.
Petcharopas A; Wongtra-Ngan S; Chinthakanan O
Int Urogynecol J; 2018 Aug; 29(8):1141-1146. PubMed ID: 29379997
[TBL] [Abstract][Full Text] [Related]
40. Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse.
Frick AC; Walters MD; Larkin KS; Barber MD
Am J Obstet Gynecol; 2010 May; 202(5):507.e1-4. PubMed ID: 20452498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
